Paclitaxel plus bevacizumab increases disease-free survival in women with advanced breast cancer

Author：

ISSN： 1745-5057

Source： Women's Health, Vol.2, Iss.3, 2006-05, pp. : 327-329

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Gemcitabine plus Paclitaxel as First-Line Chemotherapy for Patients with Advanced Breast Cancer

Oncology, Vol. 66, Iss. 1, 2004-03 ,pp. : 18-23

Karger

Access to resources Recommend Favorite

Postoperative Hyperprolactinemia Could Predict Longer Disease-Free and Overall Survival in Node-Negative Breast Cancer Patients

Oncology, Vol. 63, Iss. 4, 2002-11 ,pp. : 370-377

Karger

Access to resources Recommend Favorite

Does the Metastatic Lymph Node Ratio Influence the Disease-Free Survival of Patients with Breast Cancer: Single-Center Experiences

Oncology, Vol. 79, Iss. 1-2, 2010-11 ,pp. : 105-111

Karger

Access to resources Recommend Favorite

Two Cases of Mastectomy after Paclitaxel + Bevacizumab Therapy for Locally Advanced Breast Cancer

Case Reports in Oncology, Vol. 7, Iss. 2, 2014-05 ,pp. : 323-329

Karger

Access to resources Recommend Favorite

Expression of the High-Affinity Fluoropyrimidine-Preferring Nucleoside Transporter hCNT1 Correlates with Decreased Disease-Free Survival in Breast Cancer

Oncology, Vol. 70, Iss. 3, 2006-07 ,pp. : 238-244

Karger

Access to resources Recommend Favorite